Chimeric Antigen Receptor T Cells as Senolytic and Antifibrotic Therapy
- PMID: 33058216
- DOI: 10.1002/hep.31596
Chimeric Antigen Receptor T Cells as Senolytic and Antifibrotic Therapy
Comment on
-
Senolytic CAR T cells reverse senescence-associated pathologies.Nature. 2020 Jul;583(7814):127-132. doi: 10.1038/s41586-020-2403-9. Epub 2020 Jun 17. Nature. 2020. PMID: 32555459 Free PMC article.
References
-
- Amor C, Feucht J, Leibold J, Ho YJ, Zhu C, Alonso‐Curbelo D, et al. Senolytic CAR T cells reverse senescence‐associated pathologies. Nature 2020;583:127‐132.
-
- Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, et al. Senescence of activated stellate cells limits liver fibrosis. Cell 2008;134:657‐667.
-
- Schnabl B, Purbeck CA, Choi YH, Hagedorn CH, Brenner D. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology 2003;37:653‐664.
-
- Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence‐associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010;5:99‐118.
-
- Schultz L, Mackall C. Driving CAR T cell translation forward. Sci Transl Med 2019;11:eaaw2127.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
